Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Haas

Showing results (151-160 of 218) with videos related to

Pageof 22
Sort By:
Acta Dermato-Venereologica|April 18, 2015
Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsyMarieke H Roozeboom, Hilke Kreukels, Patty J Nelemans, et al.
The British Journal of Dermatology|September 9, 2017
Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trialJ P H M Kessels, H Kreukels, P J Nelemans, et al.
Journal of Photochemistry and Photobiology. B, Biology|July 30, 2013
Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wallT A Middelburg, H S de Bruijn, L Tettero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2019
Poor agreement between the automated risk assessment of a smartphone application for skin cancer detection and the rating by dermatologistsY Chung, A A J van der Sande, K P de Roos, et al.
International Journal of Cancer|March 3, 1995
Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP ampliconE W Eijdems, M De Haas, J M Coco-Martin, et al.
Arthritis and Rheumatism|October 20, 1998
The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosusH R Koene, M Kleijer, A J Swaak, et al.
Blood|October 15, 1996
Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infectionsE de Vries, H R Koene, J M Vossen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pumpG J Zaman, M J Flens, M R van Leusden, et al.
Clinical and Experimental Immunology|August 29, 2002
Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosisY M van der Geld, A T J Tool, J Videler, et al.
Cancer Research|April 15, 1993
Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell linesG J Zaman, C H Versantvoort, J J Smit, et al.
Pageof 22

Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
Acta Dermato-Venereologica|April 18, 2015
Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsyMarieke H Roozeboom, Hilke Kreukels, Patty J Nelemans, et al.
The British Journal of Dermatology|September 9, 2017
Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trialJ P H M Kessels, H Kreukels, P J Nelemans, et al.
Journal of Photochemistry and Photobiology. B, Biology|July 30, 2013
Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wallT A Middelburg, H S de Bruijn, L Tettero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2019
Poor agreement between the automated risk assessment of a smartphone application for skin cancer detection and the rating by dermatologistsY Chung, A A J van der Sande, K P de Roos, et al.
International Journal of Cancer|March 3, 1995
Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP ampliconE W Eijdems, M De Haas, J M Coco-Martin, et al.
Arthritis and Rheumatism|October 20, 1998
The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosusH R Koene, M Kleijer, A J Swaak, et al.
Blood|October 15, 1996
Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infectionsE de Vries, H R Koene, J M Vossen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pumpG J Zaman, M J Flens, M R van Leusden, et al.
Clinical and Experimental Immunology|August 29, 2002
Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosisY M van der Geld, A T J Tool, J Videler, et al.
Cancer Research|April 15, 1993
Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell linesG J Zaman, C H Versantvoort, J J Smit, et al.
Pageof 22